Canyon Lake CBD Pet Treats

SEQUENCING THE CANNABIS GENOME

bg-border

The Massachusetts-based company Medicinal Genomics had sequenced the entire genome of Cannabis sativa L. How will this impact scientific research and public health?

Published in full in the American Botanical Council’s HerbalGram
BY LINDSAY STAFFORD ON FEBRUARY 09, 2014
Cannabis genotyping and gene sequencing
Photo credit: Leaf Science

The August announcement that Massachusetts-based company Medicinal Genomics had sequenced the entire genome of Cannabis sativaL. received much national attention. While the development makes for attention-grabbing headlines—“Marijuana Genome Sequenced for Health, Not Highs,” “Science Cracks the Cannabis Genome”—how will it actually impact research and public health?

Medicinal Genomics founder Kevin McKernan became interested in decoding the cannabis genome when working with a clinical oncologist to sequence the DNA of cancer tumors and patients.

“As a result of this,” said McKernan, “[I] had a few friends with cancer ask about medical marijuana” (email, September 29, 2011).

Then he read Spanish scientist Manuel Guzmán’s research documenting that cannabinoids, some of the biologically active compounds in cannabis, have a favorable therapeutic index in cancerous cell cultures and animal models. McKernan said this “really drove it home,” as that finding is rare with most potential cancer drugs. Additionally, McKernan read Etienne de Meijer’s work emphasizing that the cannabis chemotype is strictly governed by genetics, “but we only knew CBD [cannabidiol] and THC[tetrahydrocannabinol] synthase sequences to date.”

“I naively figured we could sequence the whole genome for under $50k and that this had to be a priority,” he said. “Turned out to be a far more complicated genome than one could gather from the literature.”

Though other scientists and organizations have been working on sequencing cannabis, Medicinal Genomics is said to have produced the “largest known gene collection” at more than 131 billion bases of sequence. The sequence bases of C. sativa were made available on August 18th on Amazon EC2—a public cloud computing service—via Nimbus Informatics, an open source data management website. A data assembly is also available for download.

_

All content found on the hillcountrypharmhaus.com website, including: text, images, audio, or other formats were created for informational purposes only. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this Website.
If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately. Reliance on any information provided by Hill Country Pharm Haus or its employees, contracted writers, or medical professionals presenting content for publication to Hill Country Pharm Haus is done solely at your own risk.
Links to educational content not created by Hill Country Pharm Haus are taken at your own risk. Hill Country Pharm Haus is not responsible for the claims of external websites and education companies.
The statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficiency of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from healthcare practitioners. *Please consult your healthcare professional about potential interactions or other possible complications before using any of our products. The Federal Food, Drug, and Cosmetic Act require this notice. Keep Out of Reach of Children and Pets. 
All products sold contain less than 0.3% Delta-9 THC.
Seguin CBD Shop